nebag ag
Zurich, Zürichnebag.ch
Overview
nebag ag is a Swiss investment company, founded in 1996 and listed on the SIX Swiss Exchange. The firm specializes in acquiring equity stakes in financially sound Swiss small and mid-cap companies, particularly those traded outside the main stock exchange. It employs an active management approach, providing support and capital financing to its portfolio companies, and also offers mezzanine financing. The company's portfolio consists of both long-term strategic investments and short-term financial assets.
Portfolio Companies
3
Website
nebag.chInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LimmaTech Biologics | Oct 2023 | Series A | - |
| CeQur | Apr 2021 | Series C Extension | - |
| Nuance Pharma | Jun 2018 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?